• Je něco špatně v tomto záznamu ?

A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin

Z. Heger, N. Cernei, J. Kudr, J. Gumulec, I. Blazkova, O. Zitka, T. Eckschlager, M. Stiborova, V. Adam, R. Kizek,

. 2013 ; 14 (11) : 21629-46.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14063861

Doxorubicin is a commonly used antineoplastic agent in the treatment of many types of cancer. Little is known about the interactions of doxorubicin with cardiac biomolecules. Serious cardiotoxicity including dilated cardiomyopathy often resulting in a fatal congestive heart failure may occur as a consequence of chemotherapy with doxorubicin. The purpose of this study was to determine the effect of exposure to doxorubicin on the changes in major amino acids in tissue of cardiac muscle (proline, taurine, glutamic acid, arginine, aspartic acid, leucine, glycine, valine, alanine, isoleucine, threonine, lysine and serine). An in vitro interaction study was performed as a comparison of amino acid profiles in heart tissue before and after application of doxorubicin. We found that doxorubicin directly influences myocardial amino acid representation even at low concentrations. In addition, we performed an interaction study that resulted in the determination of breaking points for each of analyzed amino acids. Lysine, arginine, β-alanine, valine and serine were determined as the most sensitive amino acids. Additionally we compared amino acid profiles of myocardium before and after exposure to doxorubicin. The amount of amino acids after interaction with doxorubicin was significantly reduced (p = 0.05). This fact points at an ability of doxorubicin to induce changes in quantitative composition of amino acids in myocardium. Moreover, this confirms that the interactions between doxorubicin and amino acids may act as another factor most likely responsible for adverse effects of doxorubicin on myocardium.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063861
003      
CZ-PrNML
005      
20140709130545.0
007      
ta
008      
140704s2013 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms141121629 $2 doi
035    __
$a (PubMed)24185911
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Heger, Zbynek $u Department of Chemistry and Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech Republic. kizek@sci.muni.cz.
245    12
$a A novel insight into the cardiotoxicity of antineoplastic drug doxorubicin / $c Z. Heger, N. Cernei, J. Kudr, J. Gumulec, I. Blazkova, O. Zitka, T. Eckschlager, M. Stiborova, V. Adam, R. Kizek,
520    9_
$a Doxorubicin is a commonly used antineoplastic agent in the treatment of many types of cancer. Little is known about the interactions of doxorubicin with cardiac biomolecules. Serious cardiotoxicity including dilated cardiomyopathy often resulting in a fatal congestive heart failure may occur as a consequence of chemotherapy with doxorubicin. The purpose of this study was to determine the effect of exposure to doxorubicin on the changes in major amino acids in tissue of cardiac muscle (proline, taurine, glutamic acid, arginine, aspartic acid, leucine, glycine, valine, alanine, isoleucine, threonine, lysine and serine). An in vitro interaction study was performed as a comparison of amino acid profiles in heart tissue before and after application of doxorubicin. We found that doxorubicin directly influences myocardial amino acid representation even at low concentrations. In addition, we performed an interaction study that resulted in the determination of breaking points for each of analyzed amino acids. Lysine, arginine, β-alanine, valine and serine were determined as the most sensitive amino acids. Additionally we compared amino acid profiles of myocardium before and after exposure to doxorubicin. The amount of amino acids after interaction with doxorubicin was significantly reduced (p = 0.05). This fact points at an ability of doxorubicin to induce changes in quantitative composition of amino acids in myocardium. Moreover, this confirms that the interactions between doxorubicin and amino acids may act as another factor most likely responsible for adverse effects of doxorubicin on myocardium.
650    _2
$a aminokyseliny $x účinky léků $x metabolismus $7 D000596
650    _2
$a zvířata $7 D000818
650    _2
$a antitumorózní látky $7 D000970
650    _2
$a kur domácí $7 D002645
650    _2
$a chromatografie iontoměničová $7 D002852
650    _2
$a doxorubicin $x aplikace a dávkování $x škodlivé účinky $7 D004317
650    _2
$a nežádoucí účinky léčiv $7 D064420
650    _2
$a srdce $x účinky léků $7 D006321
650    _2
$a lidé $7 D006801
650    _2
$a myokard $x metabolismus $7 D009206
650    _2
$a nádory $x farmakoterapie $x patologie $7 D009369
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cernei, Natalia
700    1_
$a Kudr, Jiri
700    1_
$a Gumulec, Jaromir
700    1_
$a Blazkova, Iva
700    1_
$a Zitka, Ondrej
700    1_
$a Eckschlager, Tomas
700    1_
$a Stiborova, Marie
700    1_
$a Adam, Vojtěch $7 xx0064599
700    1_
$a Kizek, Rene
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 14, č. 11 (2013), s. 21629-46
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24185911 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140709130837 $b ABA008
999    __
$a ok $b bmc $g 1031345 $s 862593
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 14 $c 11 $d 21629-46 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...